awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36336005-931B725C-C3CD-4D00-8B08-631B0602F930
Q36336005-931B725C-C3CD-4D00-8B08-631B0602F930
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36336005-931B725C-C3CD-4D00-8B08-631B0602F930
Estimating cost-effectiveness associated with all-oral regimen for chronic hepatitis C in China.
P2860
Q36336005-931B725C-C3CD-4D00-8B08-631B0602F930
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36336005-931B725C-C3CD-4D00-8B08-631B0602F930
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
78898dfaf854b3f54e66a68f2afb90692d14884c
P2860
Treatment with peginterferon plus ribavirin vs. interferon plus ribavirin for 48 weeks in Chinese patients with chronic hepatitis C.